Skip to content

The Clinical Effect and Safety of Traditional She Medicine Xiaoxianggou on Early and Mid-term Knee Osteoarthritis

The Clinical Effect and Safety of Traditional She Medicine Xiaoxianggou on Early and Mid-term Knee Osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015737
Enrollment
Unknown
Registered
2018-04-17
Start date
2018-05-20
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

Treatment Group:She Medicine Xiaoxianggou Fumigation + rehabilitation training + medical treatment + health education
Control Group:Distilled water Fumigation + rehabilitation training + medical treatment + health education

Sponsors

The Second People's Hospital of Lishui
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Men or women with osteoarthritis of the knee meet the diagnostic standard OA of the knee (unilateral or bilateral); 2. Kellgren-Lawrence (radiologic criterion) grade of 1 or 3; 3. visual analogue scale (VAS) 4 to 8 by walking 24 hours; 4. Aged 40 to 80 years; 5. The informed consent form was signed by the subject or legal guardian.

Exclusion criteria

Exclusion criteria: 1. Knee surgery in the past 12 months, knee joint replacement or high tibial osteotomy on the affected side; 2. complicated with any other rheumatic disease (eg, spondyloarthropathies, rheumatoid arthritis, systemic lupus erythematosus); 3. with systemic metabolic condition or endocrinopathy affecting bone or cartilage; 4. with history of severe, uncontrolled renal, hepatic, haematological, gastrointestinal, metabolic, endocrine, pulmonary, cardiac, neurological or another disease; 5. Patients who was included in other clinical trials that would affect the evaluation results of this study.

Design outcomes

Secondary

MeasureTime frame
Knee pain;Thickness of knee joint cartilage and synovial membrane;CTX-II, COMP, MMP-3;

Primary

MeasureTime frame
Knee pain, stiffness, function;

Countries

China

Contacts

Public ContactKunqiang Yu

The Second People's Hospital of Lishui

shiweiykq@163.com+86 18157876936

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026